Radioligands for tropomyosin receptor kinase (TRK) positron emission tomography

被引:0
|
作者
Thiel, A. [1 ,2 ]
Bernard-Gauthier, V. [3 ]
Bailey, J. J. [3 ]
Kaiser, L. [4 ]
Bartenstein, P. [4 ]
Scott, P. [5 ]
Schirrmacher, R. [3 ]
机构
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada
[2] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ HT3 1E2, Canada
[3] Univ Alberta, Div Oncol Imaging, Dept Oncol, Edmonton, AB T6G 2R3, Canada
[4] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[5] Univ Michigan, Dept Radiol, Med Sch, Div Nucl Med, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP01-M08
引用
收藏
页码:529 / 530
页数:2
相关论文
共 50 条
  • [41] Positron emission tomography receptor studies in epilepsy
    Duncan, JS
    REVUE NEUROLOGIQUE, 1999, 155 (6-7) : 482 - 488
  • [42] Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update
    Jaworski, Carolin
    Iliev, Petar
    Waengler, Carmen
    Waengler, Bjoern
    Page, Brent
    Schirrmacher, Ralf
    Bailey, Justin J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2023, 33 (7-8) : 503 - 521
  • [43] Activity of larotrectinib, a highly selective inhibitor of tropomyosin receptor kinase, in TRK fusion breast cancers
    Meric-Bernstam, F.
    Shukla, N.
    Peled, N.
    Landman, Y.
    Onitilo, A.
    Montez, S.
    Ku, N. C.
    Hyman, D. M.
    Drilon, A.
    Hong, D. S.
    CANCER RESEARCH, 2019, 79 (04)
  • [44] Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
    Jiang, Tingting
    Wang, Guan
    Liu, Yao
    Feng, Lu
    Wang, Meng
    Liu, Jie
    Chen, Yi
    Ouyang, Liang
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (02) : 355 - 372
  • [45] Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor
    Jackson, Alexander
    Battle, Mark R.
    O'Shea, Dennis M.
    Chau, Wai-Fung
    Gaeta, Alessandra
    Brown, Samantha L.
    Ewan, Amanda L.
    Jones, Clare L.
    Jones, Paul A.
    Woodcraft, John L.
    Bouvet, Denis R.
    Guilbert, Benedicte B.
    Trigg, William
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (02) : 196 - 202
  • [46] Development of small-molecule tropomyosin receptor kinase(TRK) inhibitors for NTRK fusion cancers
    Tingting Jiang
    Guan Wang
    Yao Liu
    Lu Feng
    Meng Wang
    Jie Liu
    Yi Chen
    Liang Ouyang
    ActaPharmaceuticaSinicaB, 2021, 11 (02) : 355 - 372
  • [47] Clinical and genomic characteristics of tropomyosin receptor kinase (TRK) fusion cancer in community oncology practice
    Klink, Andrew
    Kavati, Abhishek
    Antoine, Ruth
    Gassama, Awa
    Kozlek, Tom
    Gajra, Ajeet
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [48] Development of Novel 11C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging
    Rong, Jian
    Yamasaki, Tomoteru
    Li, Yinlong
    Kumata, Katsushi
    Zhao, Chunyu
    Haider, Ahmed
    Chen, Jiahui
    Xiao, Zhiwei
    Fujinaga, Masayuki
    Hu, Kuan
    Mori, Wakana
    Zhang, Yiding
    Xie, Lin
    Zhou, Xin
    Collier, Thomas L.
    Zhang, Ming-Rong
    Liang, Steven
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (10): : 1419 - 1426
  • [49] New Transient Receptor Potential Vanilloid Subfamily Member 1 Positron Emission Tomography Radioligands: Synthesis, Radiolabeling, and Preclinical Evaluation
    van Veghel, Daisy
    Cleynhens, Jan
    Pearce, Larry V.
    DeAndrea-Lazarus, Ian A.
    Blumberg, Peter M.
    Van Laere, Koen
    Verbruggen, Alfons
    Bormans, Guy
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (04): : 624 - 634
  • [50] Overview of Positron Emission Tomography, Hybrid Positron Emission Tomography Instrumentation, and Positron Emission Tomography Quantification
    Kwee, Thomas C.
    Torigian, Drew A.
    Alavi, Abass
    JOURNAL OF THORACIC IMAGING, 2013, 28 (01) : 4 - 10